Delaware Court Blocks MSN Pharmaceuticals’ Quest for Additional Relief in Patent Dispute With Novartis

A Delaware federal judge has denied MSN Pharmaceuticals Inc.’s attempt to obtain further relief in its ongoing legal battle with Novartis over a generic version of Novartis’ heart medication, Entresto. The court found that the company had already been granted relief previously and declined to extend further relief “for essentially the same falling sky.” The ruling signifies another legal hurdle for MSN Pharmaceuticals in attempting to bring its generic version to market. For additional insights, the detailed report is available on Law360.